GTCbio is proud to present the Stem Cell Summit 2018, to be held in Boston, MA. The Stem Cell Summit provides information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. This summit comprises of presentations, panels and round-table discussions to highlight pre-clinical and clinical studies in regenerative medicine, immunotherapy, stem cell reprogramming, cell therapy in diabetes, regulatory policies regarding stem cell research, manufacturing and other relevant topics.
The 15th Stem Cell Summit includes two conferences including the joint plenary session:
- Plenary Keynote: Historical Perspective and State of the Industry
- Round Table Sessions
- Ready, Set, Grow – New Company/Technology Pitch Competition
- Award Ceremony and Closing Keynote Session – Predictions for the Future
Stem Cell Research & Regenerative Medicine:
- Advances in Adult Stem Cell Research
- Advances in Pluripotent Stem Cell Research
- Translation to the Clinic: What’s in the Pipeline
- Revolution in Immunotherapy
Stem Cell Product Development & Commercialization:
- Stem Cells for Drug Discovery and Disease Modeling
- Partnering between Industry, Academia and CROs to Advance Research
- Manufacturing and Scalable Processes for Cell Therapy
- Regulatory and Funding Challenges
We hope to see you in Boston!
The 2018 Advisory Committee
|2018 Advisory Board Members|
|Anthony Ting, Athersys|
|Robert Deans, BlueRock Therapeutics|
|Douglas Losordo, Caladrius Biosciences|
|Evan Y. Snyder, Sanford-Burnham Medical Research Institute|
|Mark Zimmerman, Viacyte|
|Matthew Durdy, Cell Therapy Catapult|
|Gil Sambrano, California Institute for Regenerative Medicine|
|Alain Vertès, NxR Biotechnologies GmbH|
|Khalid Shah, Harvard Medical School|
|Satish Medicetty, GTCbio|
Nordmark Biochemicals provides collagenases and other proteases used for tissue dissociation and cell isolation. The Collagenase NB products manufactured by Nordmark were previously marketed and distributed worldwide exclusively by SERVA. In 2018, Nordmark took over distribution in order to offer production, sales, marketing and support from one source. Pharmaceutical manufacturing standards result in high lot-to-lot consistency, safety and superior quality to guarantee cell viability and high yields. Supporting documentation and access to drug master files registered with the FDA are available for GMP grade users. The portfolio includes animal-free Collagenase AF-1 GMP Grade and Neutral Protease AF GMP Grade.
BioSpherix will be exhibiting the Xvivo System, world's first and only cytocentric barrier isolator optimized for cells. Economical and practical alternative to cleanrooms for cGMP compliant production of cells for clinical use. Get better contamination, process and quality control. Stop by BioSpherix booth to learn more about the only total quality platform for cells!
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.
CBSET is a not-for-profit translational research institute specializing in the evaluation of drugs, biotherapeutics, combination products, and medical devices. We provide preclinical services including in-life testing, histopathology and regulatory consulting. Our GLP-compliant facilities host a multidisciplinary team of medical, scientific and regulatory experts who actively collaborate in getting novel technologies to market.